Generics 1

Innovative

Biosimilars

Medical devices 1

Nutraceuticals

Filters

Trolamine manufacturers

1 products found

Filters

1 products found

trolamine

Cream 10 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, Canada
Manufacturer #16400
This company is a contract manufacturer of pharmaceutical products with a history dating back to 1998. They specialize in producing a range of dosage forms, including tablets, capsules, liquid orals, and both general and antibiotic injectables. They cater to major multinational corporations and well-established Indian brands. The company holds GMP certifications and boasts a strong track record in contract manufacturing. Their primary therapy areas are likely diverse due to their broad client base.

Manufacturer usually replies in 16 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.